A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University

Updated on: January 21,2024

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University

Updated on:January 21,2024

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on: January 22,2024

'Hard to lose' mutations in tumors may predict response to immunotherapy

byJohns Hopkins University School of MedicineThe figure shows the interactions between immune cells (white) and tumor cells harboring persistent mutations (red) in the context of immunotherapy (

Updated on:January 22,2024

New study supports saving more lung tissue in lung cancer surgeries

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainThe traditional treatment for early-stage non-small cell lung cancer is a lobectomy, where a surgeon eradicates cancerous t

Updated on: January 13,2024

New study supports saving more lung tissue in lung cancer surgeries

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainThe traditional treatment for early-stage non-small cell lung cancer is a lobectomy, where a surgeon eradicates cancerous t

Updated on:January 13,2024

'Tumor progressing,' 'Positive findings': Patients often confused by medical jargon

by Amy NortonIf you've ever left a medical appointment confused, it's probably not you: A new study finds that the medical jargon doctors use can be completely misunderstood by patients.Common

Updated on: January 22,2024

'Tumor progressing,' 'Positive findings': Patients often confused by medical jargon

by Amy NortonIf you've ever left a medical appointment confused, it's probably not you: A new study finds that the medical jargon doctors use can be completely misunderstood by patients.Common

Updated on:January 22,2024

Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

byPerelman School of Medicine at the University of PennsylvaniaCD5 KO enhances CAR T cell cytotoxicity. Credit:Science Immunology(2024). DOI: 10.1126/sciimmunol.adn6509The effectiven

Updated on: August 03,2024

Knockout of CD5 on CAR T cells shown to boost anti-tumor efficacy

byPerelman School of Medicine at the University of PennsylvaniaCD5 KO enhances CAR T cell cytotoxicity. Credit:Science Immunology(2024). DOI: 10.1126/sciimmunol.adn6509The effectiven

Updated on:August 03,2024

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin

Updated on: May 20,2024

An under-the-radar immune cell shows potential in fight against cancer

by University of British ColumbiaCredit: CC0 Public DomainOne of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreadin

Updated on:May 20,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on: June 28,2024

Study may explain why some triple-negative breast cancers are resistant to chemotherapy

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainTriple-negative breast cancer (TNBC) is an aggressive form of the disease accounting for 12 to 18 percent of breast can

Updated on:June 28,2024

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a

Updated on: April 14,2024

Trials supporting FDA approval of breakthrough drugs examined

(HealthDay)—Pivotal trials supporting U.S. Food and Drug Administration approvals granted Breakthrough Therapy designation often lack randomization, double-blinding, and control groups, according to a

Updated on:April 14,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on: March 06,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on:March 06,2024

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c

Updated on: March 12,2024

Fighting cancer one cell at a time

by Agency for Science, Technology and Research (A*STAR), SingaporeDrug-induced stem-cell switch (from Sox2 to Sox9) activates epigenetic re-programming driving tumour evolution in squamous cell c

Updated on:March 12,2024

Treating tumors with engineered dendritic cells

by Ecole Polytechnique Federale de LausanneCerebral tumor (glioma) of a mouse. Credit: EPFL / Michele De Palma—CC-BY-SA 4.0Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center

Updated on: May 11,2024

Treating tumors with engineered dendritic cells

by Ecole Polytechnique Federale de LausanneCerebral tumor (glioma) of a mouse. Credit: EPFL / Michele De Palma—CC-BY-SA 4.0Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center

Updated on:May 11,2024

Breast cancer survivors experience faster biological aging compared to cancer-free women, study finds

byH. Lee Moffitt Cancer Center & Research InstituteCase-control analysis of biological aging and breast cancer status. Results from multivariable linear regression models treating the biolog

Updated on: January 23,2024

Breast cancer survivors experience faster biological aging compared to cancer-free women, study finds

byH. Lee Moffitt Cancer Center & Research InstituteCase-control analysis of biological aging and breast cancer status. Results from multivariable linear regression models treating the biolog

Updated on:January 23,2024